BioMedEcon is a leading provider of health economics and outcomes research to the pharmaceutical, biotech, drug delivery, and medical device industries. Our team of experts uses scientifically rigorous, customized, and solution-oriented methods to demonstrate the clinical and economic value of a client’s products. BioMedEcon’s methodologies include the development of Phases 2 through 4 clinical studies, retrospective claims analyses, systematic literature reviews, meta-analyses, time and motion studies, and cost models to provide clients with top-quality results that highlight their products’ value to the market.
Center for Product Valuation
The Center for Product Valuation helps clients identify the unique attributes of their product(s) to determine appropriate competitive value. Simply put, the center works to highlight value at a time when the industry is facing unprecedented challenges. In addition, companies in a position to acquire a product are utilizing BioMedEcon’s services to better determine the value of the venture and carefully calculate product worth.
Center for Comparative Effectiveness
Comparative effectiveness programs consider all constituents — the provider, payer, and patient. BioMedEcon examines the unmet needs within the competitive landscape, identifies the specific value a product offers, and then develops and tests key value propositions of the product to forecast pricing and create a dissemination plan that communicates results to all constituents. The Center for Comparative Effectiveness can complete a comparative effectiveness program in as little as three months.
BioMedEcon is proud that our first-class, customized research helps pharmaceutical companies stand out in a competitive industry and provides patients with the best therapies available in the market today.